TDM of Anti-TNF Agents: The Importance of Being Active!
作者信息
Annese Vito
机构信息
Valiant Clinic & American Hospital, Dubai, United Arab Emirates.
出版信息
Inflamm Bowel Dis. 2020 Jan 6;26(2):271-272. doi: 10.1093/ibd/izz132.
PMID:31247072
Abstract
摘要
相似文献
1
TDM of Anti-TNF Agents: The Importance of Being Active!
Inflamm Bowel Dis. 2020 Jan 6;26(2):271-272. doi: 10.1093/ibd/izz132.
2
Review article: consensus statements on therapeutic drug monitoring of anti-tumour necrosis factor therapy in inflammatory bowel diseases.综述文章：炎症性肠病中抗肿瘤坏死因子治疗的治疗药物监测共识声明。
Aliment Pharmacol Ther. 2017 Dec;46(11-12):1037-1053. doi: 10.1111/apt.14368. Epub 2017 Oct 13.
3
A Survey Study of Gastroenterologists' Attitudes and Barriers Toward Therapeutic Drug Monitoring of Anti-TNF Therapy in Inflammatory Bowel Disease.炎症性肠病抗 TNF 治疗的治疗药物监测：胃肠病学家态度和障碍的调查研究。
Inflamm Bowel Dis. 2017 Dec 19;24(1):191-197. doi: 10.1093/ibd/izx023.
4
Therapeutic drug monitoring of anti-tumour necrosis factor-α agents in inflammatory bowel disease.炎症性肠病中抗肿瘤坏死因子-α制剂的治疗药物监测
Expert Opin Drug Saf. 2017 Mar;16(3):303-317. doi: 10.1080/14740338.2017.1269169. Epub 2016 Dec 22.
5
Optimization of anti-TNF therapy in patients with Inflammatory Bowel Disease.炎症性肠病患者抗TNF治疗的优化
Expert Rev Clin Pharmacol. 2016;9(3):429-39. doi: 10.1586/17512433.2016.1133288. Epub 2016 Jan 28.
6
Therapeutic drug monitoring of anti-TNF therapy in children with inflammatory bowel disease.炎症性肠病患儿抗TNF治疗的治疗药物监测
Expert Opin Drug Saf. 2018 Feb;17(2):185-196. doi: 10.1080/14740338.2018.1413090. Epub 2017 Dec 10.
7
Wide variation in the use and understanding of therapeutic drug monitoring for anti-TNF agents in inflammatory bowel disease: an inexact science?在炎症性肠病中使用和理解抗 TNF 药物的治疗药物监测方面存在广泛差异：这是一门不精确的科学吗？
Expert Opin Biol Ther. 2018 Dec;18(12):1271-1279. doi: 10.1080/14712598.2018.1537367. Epub 2018 Oct 24.
8
Therapeutic drug monitoring to improve outcome of anti-TNF drugs in pediatric inflammatory bowel disease.治疗药物监测改善儿童炎症性肠病抗 TNF 药物的疗效。
Expert Opin Drug Metab Toxicol. 2019 Jul;15(7):527-539. doi: 10.1080/17425255.2019.1630378. Epub 2019 Jun 14.
9
Therapeutic Drug Monitoring to Guide Infliximab Dose Adjustment is Associated with Better Endoscopic Outcomes than Clinical Decision Making Alone in Active Inflammatory Bowel Disease.在活动性炎症性肠病中，与仅依靠临床决策相比，通过治疗药物监测来指导英夫利昔单抗剂量调整与更好的内镜检查结果相关。
Inflamm Bowel Dis. 2017 Jul;23(7):1202-1209. doi: 10.1097/MIB.0000000000001126.
10
Therapeutic drug monitoring-based dosing of TNF inhibitors in inflammatory bowel disease: the way forward?基于治疗药物监测的 TNF 抑制剂在炎症性肠病中的剂量调整：前进的方向？
Expert Rev Clin Pharmacol. 2019 Sep;12(9):885-891. doi: 10.1080/17512433.2019.1642745. Epub 2019 Jul 18.
Zotero 插件